Microcirculation and venous ulcers: A review

Annals of Vascular Surgery

Volumn 19, Issue 6, 2005, Pages 921-927

  Pascarella, Luigi ^a   Schönbein, Geert W Schmid ^a   Bergan, John J ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CYTOKINE; ENDOTHELIAL CELL ANTIBODY; FLAVONOID; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OXYGEN RADICAL; PENTOXIFYLLINE; PROSTAGLANDIN; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

AUTOIMMUNE DISEASE; CHRONIC VEIN INSUFFICIENCY; DERMATITIS; HEMODYNAMICS; HUMAN; HYPERTENSION; INFLAMMATION; LEG ULCER; LEUKOCYTE; LEUKOCYTE ACTIVATION; MICROCIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SHEAR STRESS; SUBCUTANEOUS TISSUE;

EID: 27644544854     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-005-7661-3     Document Type: Review

References (26)

1. Homans J. The etiology and treatment of varicose ulcer of the leg. Surg Gynecol Obstet 1917;24:300-311.
2. Brewer AC. Arteriovenous shunts. BMJ 1950;ii:270.
3. Coleridge Smith PD. The drug treatment of chronic venous insufficiency and venous ulcerations. In Gloviczky P, Yao ST, eds. Handbook of Venous Disorders. Guidlines of the American Venous Forum, London: Arnold, 2001, pp 309-321.
4. Cheatle TR, McMullin GM, Farrah J, Coleridge Smith PD, Scurr HJ. Three tests of microcirculatory function in the evaluation of treatment for chronic venous insufficiency. Phlebology 1990;5:165-172.
5. Leu AJ, Leu H-J, Franzeck UK, Bollinger A. Microvascular changes in chronic venous insufficiency - a review. Cardiovasc Surg 1995;3:237-245.
6. Moyses C, Cederholm-Williams SA, Michel C. Hemoconcentration and the accumulation of white cells in the feet during venous stasis. Int J Microsc Circ Clin Exp 1987;5:311-320.
7. Thomas PRS, Nash GB, Dormandy JA. White cell accumulation in the dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. BMJ 1988;296:1693-1695.
8. Coleridge Smith PD, Thomas P, Scurr JH, Dormandy J. Causes of venous ulceration: a new hypothesis. BMJ 1988;296:1726-1727.
9. Shields DA, Andaz SK, Abeysinghe RD, Porter JB, Scurr JH, Coleridge Smith PD. Neutrophil activation in experimental ambulatory venous hypertension. Phlebology 1994;9:119-124.
10. Shields DA, Andaz SK, Sarin S, Scurr JH, Coleridge Smith PD. Plasma elastase in venous disease. Br J Surg 1994;81:1496-1499.
11. Marschel P, Schmid-Schönbein GW. Control of fluid shear response in circulating leukocytes by integrins. Ann Biomed Eng 2002;30:333-343.
12. Moazzam F, Delano FA, Zweifach BW, Schmid-Schönbein GW. The leukocyte response to fluid stress. Proc Natl Acad Sci USA 1997;94:5338-5343.
13. Peshen M, Lahaye T, Hennig B, Weyl A, Simon JC, Vanscheidt W. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1and VLA-4 in the skin is modulated in progressing stages of chronic venous insuffciency. Acta Derm Venereol (Stockh) 1999;79:27-32.
14. Murphy MA, Joyce WP, Condron C, Bouchier-Hayes D. A reduction in serum cytokine levels parallels healing of venous ulcers in patients undergoing compression therapy. Eur J Vasc Endovasc Surg 2002;23:349-352.
15. Coleridge Smith PD. Leg ulcers: biochemical factors. Phlebology 2000;15:156-161.
16. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κB activation in endothelial cells. J Biol Chem 2001;276:7614-7620.
17. Abumiya T, Sasaguri T, Taba Y, Miwa Y, Miyagi M. Shear stress induces expression of vascular endothelial growth factor receptor Flk-1/KDR through the CT-rich Sp1 binding site. Arterioscler Thromb Vasc Biol 2002;22:907-913.
18. Drinkwater SL, Smith A, Sawyer BM, Burnand KG. Effect of venous ulcer exudates on angiogenesis in vitro. Br J Surg 2002;89:709-713.
19. Pappas PJ, You R, Rameshawar P, et al. Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta 1 gene expression and protein production. J Vasc Surg 1999;3:1129-1145.
20. Guillet G, Garcia C, Sassolas B, Lonceint J, Youninou P. Antiendothelial cell antibodies in chronic leg ulcers: prevalence and significance. Ann Dermatol Venereol 2001;128:1301-1304.
21. Jantet G. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assessment and quality of life improvement with micronized flavonoids. Angiology 2002;53:245-246.
22. Herouy Y, May AE, Pronschlegel G, et al. Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinase: implications for venous ulcer formation. J Invest Dermatol 1998;111:822-827.
23. Tarlton JF, Bailey AJ, Crawford E, Jones D, Moore K, Harding KD. Prognostic value of markers of collagen remodeling in venous ulcers. Wound Repair Regen 1999;7:347-355.
24. Rogers AA, Burnett S, Lindholm C, et al. Expression of tissue-type and urokinase-type plasminogen activator activities in chronic venous leg ulcers. Vasa 1999;28:101-105.
25. Jull A, Waters J, Arroll B. Pentoxifylline for treatment of venous leg ulcers: a systematic review. Lancet 2002;359:1550-1554.
26. Barroso-Aranda J, Schmid-Schönbein GW. Pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock. Biorheology 1990;27:401-418.